Elevated levels of mitochondrion‐associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancer - Jiang, Xianhan; Li, Xun; Huang, Hai; Jiang, Funeng; Lin, Zhuoyuan; He, Huichan; Chen, Yanru; Yue, Fei; Zou, Jing; He, Yongzhong; You, Pan; Wang, Wenwei; et al. (Cancer, 2014)
Keywords: Aged; Aged, 80 and over; Animals; autophagy; Autophagy - physiology; benign prostatic hyperplasia; Biological and medical sciences; biomarker; cancer prognosis; Humans; Immunohistochemistry; leucine‐rich pentatricopeptide repeat motif‐containing protein (LRPPRC); Male; Medical sciences; Mice; Middle Aged; mitochondria; Multiple tumors. Solid tumors. Tumors in childhood (general aspects); Neoplasm Proteins - analysis; Neoplasms, Hormone-Dependent - chemistry; Nephrology. Urinary tract diseases; phosphatase and tensin homolog (PTEN); Prognosis; prostate adenocarcinomas; Prostatic Hyperplasia - metabolism; prostatic intraepithelial neoplasia; Prostatic Neoplasms - chemistry; Prostatic Neoplasms - mortality; Prostatic Neoplasms - pathology; PTEN Phosphohydrolase - physiology; Tumors; Tumors of the urinary system; Urinary tract. Prostate gland; Prognosis; Prostate disease; Biological marker; Autophagy; Mitochondria; Association; Cancerology; Benign prostatic hyperplasia; PTEN Gene; Benign neoplasm; Male genital diseases; Tumor suppressor gene; Human; Premalignant lesion; Urinary system disease; Prostate intraepithelial neoplasia; phosphatase and tensin homolog (PTEN); Malignant tumor; biomarker; Prostate adenocarcinoma; cancer prognosis; Protein; prostatic intraepithelial neoplasia; Leucine-rich repeat region; prostate adenocarcinomas; Inhibitor; Prostate cancer; leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC); Cancer; autophagy; mitochondria; benign prostatic hyperplasia